NASDAQ:LTGO | Cash Flow Statement | Latigo Biotherapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2025-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$25.8M
2026-03-31-$22.96M
2025-06-30-$25.84M
2025-03-31-$20.95M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow